Lenvatinib (LEN) in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer (RR-DTC) in SELECT: Post Hoc Analysis of Neutrophil-to-Lymphocyte Ratio (NLR)
Thyroid World Congress ePoster Library. Wirth L. 06/22/19; 272136; 160
Lori Wirth
Lori Wirth
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

Background: Elevated NLR serves as a biomarker for systemic inflammation and has been associated with poor survival outcomes in DTC. LEN is a multikinase inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, RET, and KIT.  Phase 3 SELECT enrolled patients with metastatic RR-DTC and demonstrated that LEN was superior to placebo in objective response rate (ORR; 64.8% vs 1.5%) and median progression-free survival (PFS; 18.3 months vs 3.6 months). This post hoc analysis assessed influence of NLR on SELECT outcomes.

 

Methods: In SELECT, patients with RR-DTC were randomly assigned (2:1) to LEN (24 mg/day in 28-day cycles; n=261) or placebo (n=131). At disease progression, patients in the placebo group could receive LEN. For this analysis, SELECT patients were stratified by baseline NLR of ≤3 or >3.

 

Results: Median baseline NLRs were 3.1 (LEN) and 3.2 (placebo). Median PFS was significantly longer for NLR ≤3 vs NLR >3 (HR 0.43, 95% CI: 0.29-0.65) as was overall survival (OS; HR 0.48 95% CI: 0.29-0.78). In the placebo arm, PFS and OS were also significantly improved for the NLR ≤3 group. In the LEN arm, ORR was 70% (95% CI, 61-78) for NLR ≤3 and 60% (95% CI, 51-68) for NLR >3.

 

Conclusions: PFS and OS were significantly longer for the NLR ≤3 group. ORRs were consistent with overall SELECT results and similar between NLR groups. This hypothesis-generating analysis suggests that NLR may be prognostic of outcomes. Further study is needed on association of NLR and clinical outcomes in DTC.


Background: Elevated NLR serves as a biomarker for systemic inflammation and has been associated with poor survival outcomes in DTC. LEN is a multikinase inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, RET, and KIT.  Phase 3 SELECT enrolled patients with metastatic RR-DTC and demonstrated that LEN was superior to placebo in objective response rate (ORR; 64.8% vs 1.5%) and median progression-free survival (PFS; 18.3 months vs 3.6 months). This post hoc analysis assessed influence of NLR on SELECT outcomes.

 

Methods: In SELECT, patients with RR-DTC were randomly assigned (2:1) to LEN (24 mg/day in 28-day cycles; n=261) or placebo (n=131). At disease progression, patients in the placebo group could receive LEN. For this analysis, SELECT patients were stratified by baseline NLR of ≤3 or >3.

 

Results: Median baseline NLRs were 3.1 (LEN) and 3.2 (placebo). Median PFS was significantly longer for NLR ≤3 vs NLR >3 (HR 0.43, 95% CI: 0.29-0.65) as was overall survival (OS; HR 0.48 95% CI: 0.29-0.78). In the placebo arm, PFS and OS were also significantly improved for the NLR ≤3 group. In the LEN arm, ORR was 70% (95% CI, 61-78) for NLR ≤3 and 60% (95% CI, 51-68) for NLR >3.

 

Conclusions: PFS and OS were significantly longer for the NLR ≤3 group. ORRs were consistent with overall SELECT results and similar between NLR groups. This hypothesis-generating analysis suggests that NLR may be prognostic of outcomes. Further study is needed on association of NLR and clinical outcomes in DTC.


    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings